16 research outputs found
Temporal coherence of physical, chemical and biological variables in four tropical lakes (Minas Gerais, Brazil)
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Background:
Many patients with COVID-19 have been treated with plasma containing anti-SARS-CoV-2 antibodies. We aimed to evaluate the safety and efficacy of convalescent plasma therapy in patients admitted to hospital with COVID-19.
Methods:
This randomised, controlled, open-label, platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]) is assessing several possible treatments in patients hospitalised with COVID-19 in the UK. The trial is underway at 177 NHS hospitals from across the UK. Eligible and consenting patients were randomly assigned (1:1) to receive either usual care alone (usual care group) or usual care plus high-titre convalescent plasma (convalescent plasma group). The primary outcome was 28-day mortality, analysed on an intention-to-treat basis. The trial is registered with ISRCTN, 50189673, and ClinicalTrials.gov, NCT04381936.
Findings:
Between May 28, 2020, and Jan 15, 2021, 11558 (71%) of 16287 patients enrolled in RECOVERY were eligible to receive convalescent plasma and were assigned to either the convalescent plasma group or the usual care group. There was no significant difference in 28-day mortality between the two groups: 1399 (24%) of 5795 patients in the convalescent plasma group and 1408 (24%) of 5763 patients in the usual care group died within 28 days (rate ratio 1·00, 95% CI 0·93–1·07; p=0·95). The 28-day mortality rate ratio was similar in all prespecified subgroups of patients, including in those patients without detectable SARS-CoV-2 antibodies at randomisation. Allocation to convalescent plasma had no significant effect on the proportion of patients discharged from hospital within 28 days (3832 [66%] patients in the convalescent plasma group vs 3822 [66%] patients in the usual care group; rate ratio 0·99, 95% CI 0·94–1·03; p=0·57). Among those not on invasive mechanical ventilation at randomisation, there was no significant difference in the proportion of patients meeting the composite endpoint of progression to invasive mechanical ventilation or death (1568 [29%] of 5493 patients in the convalescent plasma group vs 1568 [29%] of 5448 patients in the usual care group; rate ratio 0·99, 95% CI 0·93–1·05; p=0·79).
Interpretation:
In patients hospitalised with COVID-19, high-titre convalescent plasma did not improve survival or other prespecified clinical outcomes.
Funding:
UK Research and Innovation (Medical Research Council) and National Institute of Health Research
Pick Your Battles: The Intersection of Investment Strategy, Tax, and Compounding Returns
Phacoemulsification with Toric IOL Implantation in Alport Syndrome with Anterior Lenticonus having Spontaneously Ruptured Anterior Capsule
Antibiotics in plant tissue culture: Rifampicin effectively controls bacterial contaminants without affecting the growth of short-term explant cultures of Helianthus tuberosus
Absence of CeCl3-detectable peroxisomal glycolate-oxidase activity in developing raphide crystal idioblasts in leaves of Psychotria punctata Vatke and roots of Yucca torreyi L.
Insulin secretion, insulin sensitivity and glucose-mediated glucose disposal in Cushing's disease: a minimal model analysis
Species richness and distribution of copepods and cladocerans and their relation to hydroperiod and other environmental variables in Donana, south-west Spain
Twenty-five sites located in five wetland zones within Donana, south-west Spain were studied for copepod and cladoceran species richness and composition in relation to habitat characteristics from January to March 2004. The c-diversity of copepods and cladocerans combined varied between wetland zones, which differed significantly in conductivity, surface area and abundance of vegetation. However, there were no significant differences between zones in local species richness of either copepods or cladocerans or the two combined. Species richness was significantly higher in sites with intermediate hydroperiods (duration between 3 and 5 months) than in sites with shorter or longer hydroperiods. CCA analyses performed separately for copepods and cladocerans extracted conductivity, surface area, and vegetation cover as the main factors structuring species composition of both groups. Ours is one of the first studies of zooplankton in the natural marshes of the Donana World Heritage Site, and we recorded five species new to the Donana areaPeer reviewe